E

Essential Pharma

Specialty pharma acquiring legacy, at-risk drugs

Regional Account Director

Full-TimePosted on 10/23/2026
No salary listed
Expert
Bachelor's, MBA
Egham, UK
HybridHybrid role in Egham; travel independently across the UK and European region as required.
Sales & Account ManagementAccount Management

About the job

Requirements
  • A bachelor's degree in life sciences, business, or a related field.
  • Significant, progressive experience in senior key account management, trade, distributor management, or international business growth roles within the pharmaceutical or healthcare sector, including leading cross-functional or matrix teams.
  • Proven experience leading relationships with wholesalers, distributors, pre-wholesalers, and supply-chain partners across UK and European markets.
  • A strong track record of leading complex contract negotiations and delivering revenue and margin growth through third-party distribution.
  • Experience shaping forecasting and demand planning through market and customer insight.
  • Experience of NHS and European hospital tender processes and established medicines pricing and reimbursement environments.
  • Solid understanding of pharmaceutical regulatory, pricing, market access, and procurement frameworks across European markets.
  • Credibility operating with senior partner executives and internal leadership teams, including the Executive Management Team.
  • Fluency in English.
  • Willingness and ability to travel independently across the region when required.
  • Strategic and commercial leadership that translates group objectives into regional plans and delivers them with pace.
  • Ability to adapt to change and lead others through ambiguity.
  • Ability to challenge existing practices constructively to improve commercial performance while protecting long-term partner relationships.
  • Ability to make timely decisions within delegated authority and be accountable for regional outcomes.
  • Ability to resolve complex cross-border issues and provide recommendations to the Executive Management Team.
  • Ability to lead and influence with and without formal authority, applying emotional intelligence.
  • Ability to develop others through coaching and mentoring across matrix and indirect relationships and promote cross-functional teamwork.
  • Integrity, high ethical standards, and commitment to the company's values.
  • Commitment to continuous learning for self and team.
Responsibilities
  • Lead development and delivery of the UK and Europe commercial strategy, translating group objectives into annual regional plans, targets, and priorities agreed with the Head of Strategic Partnerships & Market Development and the Executive Management Team.
  • Take accountability for regional revenue, margin, and forecast delivery, owning demand-planning inputs, performance reporting, and corrective action plans with Finance, Commercial Operations, and Supply Chain.
  • Identify, evaluate, and pursue margin-improvement and growth opportunities, including licensing, partnership consolidation, and product launches, and present business cases to the Executive Management Team.
  • Contribute to the annual budget and long-range plan for the region, including pricing governance, payment terms, and customer credit risk.
  • Own strategic relationships with major wholesalers, pre-wholesalers, distributors, pharmacy customers, and hospital customers, serving as EPG's senior commercial point of contact in each market.
  • Lead commercial negotiations and contract renewals with wholesalers and distributors within delegated authority, securing terms that protect margin and reduce cost to serve.
  • Shape and implement the reduced-wholesale and partner-consolidation strategy, including oversight of third-party logistics and pre-wholesale relationships with downstream customers.
  • Establish partner governance for key wholesalers and distributors, including joint business plans, agreed key performance indicators and scorecards, and regular business reviews.
  • Represent EPG at senior level with customers and partners, including key trade events across European territories.
  • Direct pricing, reimbursement, tender, and market-access approaches across national systems with Commercial Operations, the Tender team, and Supply Chain.
  • Partner with Supply Chain through the Sales and Operations Planning process to ensure continuity of supply, manage stock levels and shortages, and mitigate parallel-trade and dual-pack (UK and EU) risks.
  • Lead commercial integration of newly acquired products, including Marketing Authorisation transfers, ensuring continuity of supply and customer relationships.
  • Lead cross-functional alignment with Legal, Regulatory, Medical, Supply Chain, and Finance to deliver coordinated launches and lifecycle management across the region.
  • Lead through influence across Customer Service, Commercial Operations, and partner organisations, setting service and performance expectations and building commercial capability without direct line authority.
  • Deputise for the Head of Strategic Partnerships & Market Development on UK and European matters as required.
  • Ensure regional activity complies with ABPI, EFPIA, and local codes of practice, Good Distribution Practice, Falsified Medicines Directive requirements, anti-bribery legislation, and EPG policies, and ensure partners meet quality and pharmacovigilance obligations.
  • Maintain GxP compliance by ensuring applicable standards and regulations are followed, including standard operating procedures and approved written documentation.
Desired Qualifications
  • A postgraduate qualification such as an MBA.
  • Experience in generic or established medicines; branded or promoted medicines experience is an advantage.
  • Experience designing or executing a reduced-wholesale model or partner consolidation.
  • Experience with product integration following acquisition, including Marketing Authorisation transfer.
  • Another European language.

About the company

Essential Pharma buys mature, low-volume medicines that larger pharma companies divest to keep patients supplied. It acquires at-risk and legacy drugs across rare diseases, CNS, ophthalmology, and gastroenterology, then commercializes and distributes them across about 70 countries, managing complex transfers and licenses to prevent shortages. Its growth comes from strategic acquisitions and licensing deals, such as rights to Iopidine and Methergine and the Renaissance Pharma integration, plus development-stage assets like an immunotherapy for high-risk neuroblastoma. Led by CEO Emma Johnson since 2023, the company aims to expand its portfolio and global reach to sustain access to essential medicines when big firms shift focus.

Company Size

51-200

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$990M

Headquarters

Egham, United Kingdom

Founded

2000

Get referred to Essential Pharma

See people who can refer or advise you

Benefits

  • Health Insurance
  • Life Insurance
  • Paid Sick Leave
  • Parental Leave
  • Paid Vacation
  • Flexible Work Hours
  • Performance Bonus

Growth & Insights and Company News

6 month growth

11%

1 year growth

11%

2 year growth

11%
GlobeNewswire
Jul 3rd, 2025
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Egham, UK - 03 July 2025 - Essential Pharma ("Essential" or "the Company"), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Simon Ramsden as Chief Financial Officer and Rob Smith as Chief Technology Officer, both with immediate effect.

GlobeNewswire
May 6th, 2025
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial

Egham, UK - 6th May 2025 - Essential Pharma ("Essential" or "the Company"), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Duncan Ferguson as Vice President, Commercial.

GlobeNewswire
Apr 30th, 2025
Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director

Egham, UK - 30 April 2025 - Essential Pharma ("Essential" or "the Company"), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Jonathan Arnold as a Non-Executive Director, with immediate effect.

Insider Media
Dec 12th, 2024
Pharma group completes £741m recapitalisation to build portfolio of rare disease medicines

Following the transaction, Lee Morley, appointed as non-executive director to the board in 2023, will assume the role of chairman of Essential Pharma, succeeding Dr Patrick Vink.

Real Deals
Dec 12th, 2024
Gyrus Capital raises €600m for Essential Pharma

Gyrus Capital, based in Geneva, has successfully raised a €600 million single-asset continuation vehicle to extend its hold on Essential Pharma.